Zahi Mitri
11PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Apr 14, 2026
The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer.Hyejee Ohm, Caroline Lohrisch, Nathalie LeVasseur
|Jun 13, 2025
Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer.Daniel Bottomly, Christina Zheng, Allison L Creason
|Jul 24, 2023
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.R C Coombes, Sacha Howell, Simon R Lord
|Mar 22, 2023
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.Malinda T West, Shaun M Goodyear, Evthokia A Hobbs
|Sep 09, 2022
Impact of TP53 mutations in Triple Negative Breast Cancer.Zahi I Mitri, Nour Abuhadra, Shaun M Goodyear
|Oct 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.Marilyne Labrie, Allen Li, Allison Creason
Pageof 2
Frequent Collaborators
3 joint publications
Allen Li
3 joint publications
R C Coombes
3 joint publications
Matthew G Krebs
3 joint publications
Allison L Creason
3 joint publications
William Gradishar
3 joint publications
Simak Ali
3 joint publications
Carlo Palmieri
3 joint publications
Rinath Jeselsohn
3 joint publications
Simon R Lord
3 joint publications
Patrick Ward
